HLA typing is essential in cancer for several reasons. Firstly, it helps in the selection of compatible donors for stem cell and bone marrow transplants, which are often required for treating blood cancers like leukemia and lymphoma. Secondly, it aids in understanding the patient's immune response to tumors and the effectiveness of immunotherapy. Finally, HLA typing can help predict the likelihood of adverse reactions to certain cancer treatments.
